Labcorp launches companion diagnostic for ovarian cancer treatment
Labcorp (NYSE: LH) announced the nationwide availability of Agilent Technologies' PD-L1 IHC 22C3 pharmDx, a companion diagnostic approved by the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)